Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, January 27, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
admin
-
January 18, 2025
Latest Pharma-News
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
admin
-
January 18, 2025
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
Tiziana Life Sciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies
admin
-
April 9, 2020
0
Latest Pharma-News
Avacta and Cytiva collaborating on COVID-19 Rapid Test
admin
-
April 9, 2020
0
Latest Pharma-News
Roche provides regulatory update on Risdiplam for the treatment of Spinal Muscular Atrophy (SMA)
admin
-
April 9, 2020
0
Latest Pharma-News
Oxford Biomedica joins Consortium to rapidly develop a COVID-19 vaccine candidate
admin
-
April 8, 2020
0
Latest Pharma-News
Lancaster University academic sees positive signs from first published clinical trial for treatment of COVID-19
admin
-
April 8, 2020
0
Latest Pharma-News
New vaccine platform used to develop COVID-19 candidates
admin
-
April 8, 2020
0
Latest Pharma-News
Izana intiates study assessing namilumab for COVID-19
admin
-
April 8, 2020
0
Latest Pharma-News
Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
admin
-
April 8, 2020
0
Latest Pharma-News
FDA Accepts IND for NK Cell Therapy CYNK-001 to Treat Patients with COVID-19
admin
-
April 7, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
admin
-
April 5, 2020
0
Latest Pharma-News
Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
admin
-
April 5, 2020
0
1
...
124
125
126
...
145
Page 125 of 145
- Advertisment -
Most Read
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
January 24, 2025
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
January 18, 2025
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
January 18, 2025